Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.18B |
| 2 |
STER
Sterling Check Corp. Common Stock
STER
|
+$1.57B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.35B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.27B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$928M |
| 2 |
Walmart Inc
WMT
|
+$502M |
| 3 |
Willis Towers Watson
WTW
|
+$462M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$449M |
| 5 |
Salesforce
CRM
|
+$350M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.7% |
| 2 | Consumer Discretionary | 9.53% |
| 3 | Financials | 8.37% |
| 4 | Healthcare | 7.77% |
| 5 | Communication Services | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
SSR Mining
SSRM
$6.48B
| $5.56M | ﹤0.01% |
382,371
-136,430
| -26% | -$2.16M |
|
|
SLY
3227
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $5.56M | ﹤0.01% |
58,654
| – | – |
|
|
SJR
3228
DELISTED
Shaw Communications Inc.
SJR
| $5.56M | ﹤0.01% |
191,315
-101,004
| -35% | -$2.93M |
|
3229
Innoviva
INVA
$1.48B
| $5.55M | ﹤0.01% |
332,162
+192,039
| +137% | +$2.87M |
|
3230
BioLife Solutions
BLFS
$1.7B
| $5.55M | ﹤0.01% |
131,100
+96,701
| +281% | +$4.66M |
|
|
RTLR
3231
DELISTED
Rattler Midstream LP Common Units
RTLR
| $5.54M | ﹤0.01% |
471,852
-1,285,362
| -73% | -$13.9M |
|
|
VLRS
3232
Controladora Vuela Compania de Aviacion
VLRS
$939M
| $5.54M | ﹤0.01% |
253,980
+81,707
| +47% | +$1.71M |
|
3233
CALL
Novavax
NVAX
$1.31B
| $5.54M | ﹤0.01% |
26,700
| – | – |
|
3234
Pulmonx
LUNG
$87.6M
| $5.53M | ﹤0.01% |
153,704
+59,624
| +63% | +$2.35M |
|
|
AAC
3235
DELISTED
Ares Acquisition Corporation
AAC
| $5.53M | ﹤0.01% |
567,359
-3,270
| -0.6% | -$31.8K |
|
3236
Univest Financial
UVSP
$1.18B
| $5.5M | ﹤0.01% |
200,804
-19,816
| -9% | -$532K |
|
3237
Scorpio Tankers
STNG
$3.81B
| $5.49M | ﹤0.01% |
296,182
+18,043
| +6% | +$301K |
|
|
INBX
3238
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $5.48M | ﹤0.01% |
164,533
+112,951
| +219% | +$3.44M |
|
3239
Pan American Silver
PAAS
$21.6B
| $5.48M | ﹤0.01% |
235,344
+64,357
| +38% | +$1.68M |
|
3240
PUT
Dollar General
DG
$27.9B
| $5.47M | ﹤0.01% |
25,800
+4,000
| +18% | +$903K |
|
3241
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
| $5.47M | ﹤0.01% |
115,191
+110,301
| +2,256% | +$5.34M |
|
|
CVAC
3242
PUT
DELISTED
CureVac
CVAC
| $5.46M | ﹤0.01% |
+100,000
| New | +$6.03M |
|
3243
P3 Health Partners
PIII
$38.5M
| $5.46M | ﹤0.01% |
11,072
-110
| -1% | -$54.2K |
|
3244
Shinhan Financial Group
SHG
$35.6B
| $5.45M | ﹤0.01% |
161,967
+19,059
| +13% | +$637K |
|
3245
Central Pacific Financial
CPF
$1B
| $5.45M | ﹤0.01% |
212,133
-56,033
| -21% | -$1.4M |
|
3246
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $5.42M | ﹤0.01% |
333,159
+50,338
| +18% | +$861K |
|
|
B
3247
PUT
Barrick Mining
B
$73.2B
| $5.42M | ﹤0.01% |
+300,000
| New | +$6.02M |
|
3248
Prothena Corp
PRTA
$450M
| $5.41M | ﹤0.01% |
75,909
+2,645
| +4% | +$164K |
|
3249
Altimmune
ALT
$599M
| $5.39M | ﹤0.01% |
476,805
+454,960
| +2,083% | +$5.53M |
|
3250
Cartesian Therapeutics
RNAC
$268M
| $5.39M | ﹤0.01% |
43,211
-10,600
| -20% | -$1.28M |
|
Similar funds
Goldman Sachs's Q3 2021 Portfolio in Review
As of Q3 2021, Goldman Sachs held 6,784 positions worth $471B, up 5.6% from $446B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs deployed $36.8B of net new capital in Q3 2021, opening 620 new positions and adding to 2,690 existing holdings. Its largest new stake was Sterling Check Corp. Common Stock: 59,953,230 shares worth $1.56B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $928M trimmed.
- Goldman Sachs's largest Q3 2021 buy was Sterling Check Corp. Common Stock: 59,953,230 shares worth $1.56B.
- Goldman Sachs added most to Alibaba in Q3 2021, an estimated $3.18B increase.
- Goldman Sachs's biggest Q3 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $928M.
- Goldman Sachs fully exited Brookfield Property Partners L.P. Limited Partnership Units in Q3 2021, selling an estimated $327M.
- Goldman Sachs's ten largest holdings make up 19% of its $471B portfolio in Q3 2021.
- Goldman Sachs opened 620 new positions and closed 595 in Q3 2021.
- Goldman Sachs's portfolio value rose 5.6% quarter-over-quarter to $471B.
Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.